J&J granted generic injunction against Mylan

<p>The injunction has been granted prior to a final court decision on the validity of the patent. <br /><br />The preliminary injunction will be in effect until the district court has rendered a final decision regarding the validity of the Topomax patent. A trial date has not yet been set. The Topamax patent expires in September 2008. <br /><br />Topamax is indicated as monotherapy in patients with newly diagnosed epilepsy or for conversion to monotherapy in patients with epilepsy. <br /><br />Topamax is also indicated as adjunctive therapy for patients with partial onset seizures or generalized tonic-clonic seizures and as a therapy for the treatment of seizures associated with Lennox Gastaut syndrome. Topomax is indicated in adults for the prophylaxis of migraine headache.</p>